SCHEMBL20022971

SCHEMBL20022971

O=C(Cc1ccc2c(c1)OCO2)C(=O)OCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
CYP3A4 P08684 2/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2C19 P33261 1/20 0.63
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
TSHR P16473 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
TP53 P04637 1/20 0.58
MAPT P10636 1/20 0.58
ATM Q13315 1/20 0.58
HPGD P15428 1/20 0.54
MAOB P27338 3/20 0.53
MAOA P21397 1/20 0.53
SIGMAR1 Q99720 2/20 0.51
FAAH O00519 1/20 0.51
MGLL Q99685 1/20 0.51
ACE P12821 1/20 0.51
EDNRA P25101 2/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8181400 0.87 ALDH1A1 (0.56) ALDH1A1CYP3A4CYP1A2CYP2C19NPC1
SCHEMBL8736580 0.79 ALDH1A1 (0.68) ALDH1A1CYP3A4CYP1A2CYP2C19NPC1
SCHEMBL7990509 0.78 ALDH1A1 (0.59) ALDH1A1CYP3A4CYP1A2CYP2C19NPC1
SCHEMBL2461730 0.78 CYP3A4 (1.00) ALDH1A1CYP3A4CYP1A2CYP2C19NPC1
SCHEMBL31114377 0.78 CYP3A4 (1.00) ALDH1A1CYP3A4CYP1A2CYP2C19NPC1
SCHEMBL31171631 0.78 ACE (0.58) ALDH1A1CYP3A4NPC1RAB9ATSHR
SCHEMBL31171638 0.78 ACE (0.58) ALDH1A1CYP3A4NPC1RAB9ATSHR
SCHEMBL7636977 0.78 ALDH1A1 (0.66) ALDH1A1HTT
SCHEMBL6800842 0.77 ACE (0.61) ALDH1A1CYP3A4CYP1A2CYP2C19NPC1
SCHEMBL27969666 0.76 CYP3A4 (0.62) ALDH1A1CYP3A4CYP1A2CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093981-A1 2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors GENZYME CORPORATION 2018-04-05 US disclosed
US-20180093981-A1 2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors GENZYME CORPORATION 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093981-A1 2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors ASAH2, GBA1, GAA ALDH1A1 961/4885CYP3A4 4407/4885CYP1A2 1873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.